Evidence map›Paper›PMID 11113200›Full record

ArticleMolecular and cellular biology2001

MAT1-modulated CAK activity regulates cell cycle G(1) exit.

L Wu, P Chen, C H Shum, C Chen, L W Barsky, K I Weinberg, A Jong, T J Triche

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. MAT1 correlates with molecular subtypes and predicts poor survival in breast cancer.Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2018
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Loss of CAK phosphorylation of RAR{alpha} mediates transcriptional control of retinoid-induced cancer cell differentiation.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2010
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

L WuDepartment of Pathology, Childrens Hospital Los Angeles Research Institute, Los Angeles, California 90027, USA. lingtaow@hsc.usc.edu
P Chen
C H Shum
C Chen
L W Barsky
K I Weinberg
A Jong
T J Triche
University of Southern California · USChildren's Hospital of Los Angeles · USPalmetto Hematology Oncology · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cyclin-dependent kinase (CDK)-activating kinase (CAK) is involved in cell cycle control, transcription, and DNA repair (E. A. Nigg, Curr. Opin. Cell. Biol. 8:312-317, 1996). However, the mechanisms of how CAK is integrated into these signaling pathways remain unknown. We previously demonstrated that abrogation of MAT1 (ménage à trois 1), an assembly factor and targeting subunit of CAK, induces G(1) arrest (L. Wu, P. Chen, J. J. Hwang, L. W. Barsky, K. I. Weinberg, A. Jong, and V. A. Starnes, J. Biol. Chem. 274:5564-5572, 1999). This result led us to investigate how deregulation of CAK by MAT1 abrogation affects the cell cycle G(1) exit, a process that is regulated most closely by phosphorylation of retinoblastoma tumor suppressor protein (pRb). Using mammalian cellular models that undergo G(1) arrest evoked by antisense MAT1 abrogation, we found that deregulation of CAK inhibits pRb phosphorylation and cyclin E expression, CAK phosphorylation of pRb is MAT1 dose dependent but cyclin D1/CDK4 independent, and MAT1 interacts with pRb. These results suggest that CAK is involved in the regulation of cell cycle G(1) exit while MAT1-modulated CAK formation and CAK phosphorylation of pRb may determine the cell cycle specificity of CAK in G(1) progression.

Indexed as

G1 PhaseCell DivisionCyclin-Dependent Kinase-Activating KinaseCyclin-Dependent KinasesCyclinsGene Expression Regulation, EnzymologicHumansNeoplasm ProteinsPhosphorylationProtein BindingProtein Serine-Threonine KinasesRecombinant Fusion ProteinsRetinoblastoma ProteinSubstrate SpecificityTransduction, GeneticTransfectionCyclin-Dependent Kinase-Activating KinaseCyclin-Dependent KinasesCyclinsNeoplasm ProteinsProtein Serine-Threonine KinasesRecombinant Fusion ProteinsRetinoblastoma Protein

Identifiers

PMID11113200
PMCPMC88799
OpenAlexW2116320149

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.